Literature DB >> 3360271

Colchicine therapy of the renal amyloidosis of ulcerative colitis.

S Meyers1, H D Janowitz, V V Gumaste, R G Abramson, L J Berman, V S Venkataseshan, S H Dickman.   

Abstract

Two patients with severe proteinuria, due to renal amyloidosis complicating chronic ulcerative colitis, improved remarkably with colchicine therapy. One patient with an initial daily urine protein excretion of 13.70 g had a reduction within 2 mo to 6.50 g and to 0.37 g after 9 yr. The other patient's daily urine protein excretion was 9.00 g. This was reduced to 5.10 g/day within 3 mo and was 0.53 g/day by 8 mo. Renal function remained stable or improved during the period of therapy. Colchicine resulted in rapid and prolonged benefit for these patients, despite their amyloid-induced nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3360271     DOI: 10.1016/0016-5085(88)90692-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  4 in total

Review 1.  Colchicine--expanding horizons.

Authors:  A Schattner
Journal:  Postgrad Med J       Date:  1991-03       Impact factor: 2.401

Review 2.  Amyloidosis complicating inflammatory bowel disease. A case report and review of the literature.

Authors:  M J Gitkind; S C Wright
Journal:  Dig Dis Sci       Date:  1990-07       Impact factor: 3.199

3.  Amyloidosis in rheumatic diseases.

Authors:  J Barash
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

Review 4.  Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.

Authors:  Fotios S Fousekis; Vasileios I Theopistos; Konstantinos H Katsanos; Epameinondas V Tsianos; Dimitrios K Christodoulou
Journal:  Gastroenterology Res       Date:  2018-04-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.